Stockreport

Exelixis, Bristol-Myers stocks get a boost from upbeat trial results of a Kidney cancer treatment [MarketWatch]

Exelixis, Inc.  (EXEL) 
Last exelixis, inc. earnings: 2/25 04:05 pm Check Earnings Report
PDF Shares of Exelixis Inc. shot up 8.1%, while Bristil-Myers Squibb Co.'s stock slipped 0.3% in premarket trading Monday, after the companies said a phase 3 study of a trea [Read more]